Arkolith/Insider Trading/ACAD/Form 4

Kihara James

PRINCIPAL ACCOUNTING OFFICERACADIA PHARMACEUTICALS INC (ACAD) · full profile →Form 4 · filed May 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$29K
Net Open-Market Flow
-$29K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 4, 2026Sell(S)1K$21.79$29K29K
May 1, 2026Option exercise(M)3K——30K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 1, 2026Option exercise(M)3K—$03K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001816160-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML